FIELD: medicine.
SUBSTANCE: invention can be used to diagnose festering postnecrotic pancreatic pseudocyst. To do this, a patient's blood phagocytic activity was determined by the level of expression of CD 14+/HLA-DR+ Flow cytometry and statistical ROC-analysis. When the content of CD14+/ HLA-DR+ below 85% are diagnosed with festering postnecrotic pancreatic pseudocysts.
EFFECT: use this method to diagnose festering postnecrotic pancreatic pseudocysts that allows you to define the tactics of such patients, and choices of surgery.
1 cl, 2 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR ASSESSING SEVERITY OF PATIENTS SUFFERING POSTNECROTIC PANCREATIC CYSTS | 2015 |
|
RU2588305C1 |
| DIAGNOSTIC TECHNIQUE FOR MATURITY OF POSTNECROTIC PANCREATIC PSEUDOCYST | 2010 |
|
RU2466393C2 |
| METHOD FOR EVALUATION OF PATIENTS WITH PANCREATIC POSTNEKROTIC STATES | 2010 |
|
RU2442162C1 |
| DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR POSTNECROTIC PANCREATIC CYSTS | 2010 |
|
RU2466394C2 |
| DIAGNOSTIC TECHNIQUE FOR SPONTANEOUS SECONDARY IMMUNE DEFICIENCY IN CHILDREN WITH PRIMARY PERITONITIS | 2013 |
|
RU2527332C1 |
| METHOD FOR DETERMINING SUBPOPULATION COMPOSITION OF SKIN CELLS AND OBTAINING SKIN CYTOIMMUNOGRAM | 2016 |
|
RU2630607C1 |
| METHOD FOR DETERMINING INDICATIONS FOR VACCINATION AGAINST INFLUENZA/COVID-19 | 2022 |
|
RU2795602C1 |
| METHOD FOR DIAGNOSING PANCREATIC POSTNECROTIC CYSTS MATURITY | 2006 |
|
RU2310859C1 |
| DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR DEGREE OF RHEUMATOID ARTHRITIS ACTIVITY | 2011 |
|
RU2456611C1 |
| DIAGNOSTIC TECHNIQUE OF FORMATION OF POST-INFECTIOUS CYSTS OF PANCREAS | 2019 |
|
RU2720165C1 |
